This event is co-sponsored by the UF College of Pharmacy Office of Continuing Pharmacy Education and the Office of Diversity, Inclusion and Health Equity. Program Details Intended Audience: Pharmacists in all practice settingsUniversal Activity Number: 0012-0000-22-010-H02-PContact Hours: 1.0 hour of ACPE approved continuing education for…
This event is co-sponsored by the UF College of Pharmacy Office of Continuing Pharmacy Education and the Office of Diversity, Inclusion and Health Equity. Program Details Intended Audience: Pharmacists in all practice settingsUniversal Activity Number: 0012-0000-22-008-H04-PContact Hours: 1.0 hours of ACPE approved continuing education for…
This event is co-sponsored by the UF College of Pharmacy Office of Continuing Pharmacy Education and the Office of Diversity, Inclusion and Health Equity. Program Details Intended Audience: Pharmacists in all practice settingsUniversal Activity Number: 0012-0000-22-009-H04-PContact Hours: 1.0 hours of ACPE approved continuing education for…
In this continuing education program, we will discuss ways that healthcare providers can become more aware of barriers to COVID-19 vaccination uptake in underserved communities. Barriers range from physical and logistical barriers to myths and beliefs that result in vaccine hesitancy. Awareness of such issues will equip healthcare providers with the appropriate tools to accommodate for specific barriers in hopes to increase COVID-19 vaccination rates in underserved communities.
This event is co-sponsored by the UF College of Pharmacy Office of Continuing Pharmacy Education and the Office of Diversity, Inclusion and Health Equity. Program Details Intended Audience: Pharmacists in all practice settingsUniversal Activity Number: 0012-0000-21-026-H04-PContact Hours: 1.5 hours of ACPE approved continuing education for…
Pharmacists can play a critical role in the care of persons living with human immunodeficiency virus (HIV). This activity will provide an overview of the history, epidemiology, pathophysiology, and viral targets of antiretroviral therapy (ART).
